Great 10Q: Cash+Restricted cash jumped to almost $40m,while O/S still 1.5m (cap under $6m),+upcoming Catalysts
so many catalysts and clinical, Germany,United Kingdom,Spain,New Markets - Turkey...thats why institutional investors banking on her,and just closed $35 Million Funding Round. won't trade under $6m for long imo.